Clinical Trial Update: Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the long-term safety and efficacy of TQH2722 Injection for chronic rhinosinusitis with or without nasal polyps, and the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• TQH2722 Injection (TQH2722)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Rhinosinusitis | Phase 2 | Status: RECRUITING